ESR1 and hepatocellular carcinoma: In a preclinical model of hepatocellular carcinoma (HCC), estrogen receptor signaling increased cancer cell death through NLRP3 inflammasome-initiated, caspase-1-dependent pyroptosis and inhibition of autophagy in cancer cells [177].